V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20211606 | 20078634 | 1.74 | 51.4 | null | 2017-10-27 | 2017-11-10 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 101181299 |
| 20211607 | 20078635 | 1.62 | 68 | Palliative (P) | 2018-12-08 | 2018-12-18 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101397736 |
| 20211608 | 20078636 | 1.61 | 45.8 | Palliative (P) | 2019-11-24 | 2019-11-25 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100682505 |
| 20211611 | 20078637 | 0 | 0 | Palliative (P) | 2019-05-02 | 2019-06-07 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100532361 |
| 20211618 | 20078638 | 1.73 | 80 | Palliative (P) | 2017-03-28 | 2017-03-28 | Capecitabine (21days) + Carboplatin | 02 | N | DOXORUBICIN EMBOLISATION | 101176009 |
| 20211619 | 20078639 | 1.69 | 82.2 | 03 | 2016-09-17 | 2016-09-26 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 100861171 |
| 20211622 | 20078640 | null | 39.7 | Adjuvant (A) | 2017-06-11 | 2017-06-30 | Cisplatin +Fluorouracil (2 wk) | N | N | CISPLATIN + FLUOROURACIL | 101088133 |
| 20211626 | 20078641 | 0 | 0 | Curative (C) | 2017-04-18 | 2017-06-09 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 101565646 |
| 20211627 | 20078642 | 1.73 | 78.9 | null | 2019-10-25 | 2019-11-06 | Cisplatin + Fluorouracil + RT 5day | 02 | null | CISPLATIN + FLUOROURACIL | 100809976 |
| 20211630 | 20078643 | 0 | 0 | 03 | 2017-08-16 | 2017-09-06 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100575097 |
| 20211631 | 20078644 | 1.54 | 40.6 | 03 | 2019-10-10 | 2019-11-07 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101574673 |
| 20211634 | 20078645 | 0 | 0 | Palliative (P) | 2022-02-08 | 2022-02-10 | Doxorubicin chemoembolisation | N | N | DOXORUBICIN EMBOLISATION | 100880660 |
| 20211638 | 20078646 | 1.52 | 66.55 | Curative (C) | 2018-06-04 | 2018-06-26 | Cisplatin +Fluorouracil (3 wk) | N | Y | CISPLATIN + FLUOROURACIL | 101184983 |
| 20211643 | 20078647 | 1.75 | 70.2 | 03 | 2020-04-27 | 2020-04-27 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101175497 |
| 20211645 | 20078648 | 1.61 | 113 | Neo-adjuvant (N) | 2018-05-20 | 2018-05-24 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100737291 |
| 20211652 | 20078649 | 0 | 0 | Neo-adjuvant (N) | 2017-03-29 | 2017-04-12 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100376919 |
| 20211662 | 20078650 | 1.78 | 73 | Neo-adjuvant (N) | 2017-05-12 | 2017-05-23 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100934687 |
| 20211665 | 20078651 | 1.48 | 98.8 | Curative (C) | 2019-09-20 | 2019-09-20 | Capecitabine (21days) + Carboplatin | 02 | Y | CAPECITABINE + CARBOPLATIN | 100144285 |
| 20211666 | 20078652 | 1.73 | 40.2 | null | 2018-04-04 | 2018-04-04 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101197653 |
| 20211673 | 20078653 | 1.72 | 101 | Palliative (P) | 2017-01-19 | 2017-02-01 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100408345 |
| 20211675 | 20078654 | 1.67 | 49 | Palliative (P) | 2018-06-25 | 2018-07-02 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL | 101557749 |
| 20211683 | 20078655 | 1.71 | 72.1 | Palliative (P) | 2019-07-23 | 2019-07-23 | Capecitabine (21days) + Carboplatin | N | N | CISPLATIN + FLUOROURACIL | 101380847 |
| 20211688 | 20078656 | 1.59 | 92 | null | 2016-09-26 | 2016-10-10 | Capecitabine (21days) + Carboplatin | 02 | null | DOXORUBICIN EMBOLISATION | 100187592 |
| 20211694 | 20078657 | 1.62 | 80.4 | Neo-adjuvant (N) | 2018-08-17 | 2018-08-24 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100790072 |
| 20211695 | 20078658 | 1.85 | 76.4 | Palliative (P) | 2016-02-20 | 2016-03-05 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101692068 |
| 20211699 | 20078659 | 1.69 | 77.3 | Palliative (P) | 2018-04-11 | 2018-04-18 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100387519 |
| 20211705 | 20078660 | 1.76 | null | Neo-adjuvant (N) | 2017-12-29 | 2018-01-23 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100650223 |
| 20211712 | 20078661 | 0 | 0 | Palliative (P) | 2019-04-24 | 2019-06-02 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100883654 |
| 20211714 | 20078662 | 1.53 | null | Neo-adjuvant (N) | 2018-02-18 | 2018-02-20 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100248246 |
| 20211716 | 20078663 | 1.88 | 78 | Palliative (P) | 2019-02-26 | 2019-04-02 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100013165 |
| 20211728 | 20078664 | 1.61 | 82.35 | Neo-adjuvant (N) | 2019-11-21 | 2019-12-06 | Capecitabine (21days) + Carboplatin | 02 | N | TRIAL UNSPECIFIED | 101379110 |
| 20211729 | 20078665 | 1.72 | 45 | Palliative (P) | 2017-06-08 | 2017-06-10 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100070495 |
| 20211733 | 20078666 | 1.65 | 54.4 | null | 2016-05-07 | 2016-05-07 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100448682 |
| 20211737 | 20078667 | 1.7 | 50.75 | null | 2017-03-28 | 2017-03-28 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100201593 |
| 20211742 | 20078668 | 0 | 97.15 | Palliative (P) | 2017-04-01 | 2017-04-26 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101302799 |
| 20211743 | 20078669 | 1.78 | 85 | Neo-adjuvant (N) | 2016-12-09 | 2016-12-22 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100330718 |
| 20211745 | 20078670 | 1.58 | 51.7 | Adjuvant (A) | 2016-09-20 | 2016-10-06 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100290310 |
| 20211746 | 20078671 | 1.77 | 86.3 | null | 2016-07-17 | 2016-08-09 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 100719615 |
| 20211749 | 20078672 | 1.49 | 46.4 | null | 2018-10-04 | 2018-11-02 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100393622 |
| 20211754 | 20078673 | 1.65 | 68.3 | Palliative (P) | 2017-05-02 | 2017-05-02 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100408145 |
| 20211760 | 20078674 | 1.7 | 93.6 | Palliative (P) | 2017-12-28 | 2018-01-08 | CAPECITABINE + CARBOPLATIN | 02 | N | TRIAL UNSPECIFIED | 101007784 |
| 20211768 | 20078675 | 1.42 | 108.1 | Curative (C) | 2018-04-23 | 2018-04-24 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 101404871 |
| 20211772 | 20078676 | 1.85 | 73.65 | Palliative (P) | 2019-01-31 | 2019-02-11 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101589978 |
| 20211778 | 20078677 | 1.66 | 85.8 | Neo-adjuvant (N) | 2016-08-27 | 2016-10-02 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 100929890 |
| 20211779 | 20078678 | 1.65 | 59.1 | null | 2019-09-11 | 2019-09-24 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 101149212 |
| 20211785 | 20078679 | 0 | 0 | Neo-adjuvant (N) | 2018-03-06 | 2018-04-17 | Doxorubicin chemoembolisation | 99 | null | DOXORUBICIN EMBOLISATION | 100153353 |
| 20211786 | 20078680 | 0 | 0 | Curative (C) | 2019-12-04 | 2019-12-18 | CAPECITABINE + CARBOPLATIN | 02 | N | DOXORUBICIN EMBOLISATION | 101322623 |
| 20211787 | 20078681 | 1.71 | 94.7 | Palliative (P) | 2018-07-30 | 2018-08-03 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100497499 |
| 20211788 | 20078682 | 1.72 | null | Neo-adjuvant (N) | 2018-12-08 | 2018-12-27 | Cisplatin + Fluorouracil + RT 5day | 02 | N | CISPLATIN + FLUOROURACIL | 101266274 |
| 20211793 | 20078683 | 1.61 | 102 | Palliative (P) | 2016-06-01 | 2016-06-01 | Cisplatin +Fluorouracil (3 wk) | N | N | CISPLATIN + FLUOROURACIL | 100095164 |